Accelerating research toward faster diagnoses,
better treatments, and a cure.

Enrollment of Non-White Participants and Reporting of Race and Ethnicity in Phase III Trials of Multiple Sclerosis DMTs

This research article evaluates ethnic and racial representation in DMT clinical trials and how it has evolved over time. Non-White PwMS are significantly underreported and underrepresented in MS trials. The significance for patients and their HCPs who lack relevant evidence to make informed decisions about their care is highlighted.

Click here to access this resource.

Authors: Onuorah, et al.
Publication: Neurology
Year: 2022

It's important for me to stay connected with the community of researchers who are looking for answers. I consider it my duty to be part of the discovery process. I am not anonymous; I am not just a number. I am a resilient person who happens to have a chronic disease. The mission of ACP and iConquerMS grew as a response to the needs of people affected by MS that were not being addressed by the traditional paths of research. ACP and iConquerMS allow me the opportunity to drive, shape, and take charge of the research that will have a direct impact on my life, and the lives of others living with this disease.

~ Karen J.Person Living with MS

ways to help share your insights, experience, and information, and connect with researchers studying the disease.

Accelerating research toward faster diagnoses, better treatments, and a cure.

Accelerating research toward faster diagnoses,
better treatments, and a cure.